<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>24</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2025</Year>
        <Month>01</Month>
        <Day>14</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Effect of Remimazolam on Cellular Immune Response and Postoperative Recovery in Patients Undergoing Laparoscopic Colorectal Cancer Surgery</title>
    <FirstPage>41</FirstPage>
    <LastPage>51</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Jianyan</FirstName>
        <LastName>Wu</LastName>
        <affiliation locale="en_US">School of Anesthesiology, Shandong Second Medical University, Weifang, China AND Affiliated Hospital of Shandong Second Medical University, Weifang, China AND Jiaozhou Hospital, East Hospital Affiliated to Tongji University, Qingdao, China</affiliation>
      </Author>
      <Author>
        <FirstName>Huijie</FirstName>
        <LastName>Ma</LastName>
        <affiliation locale="en_US">School of Anesthesiology, Shandong Second Medical University, Weifang, China AND Affiliated Hospital of Shandong Second Medical University, Weifang, China</affiliation>
      </Author>
      <Author>
        <FirstName>Boya</FirstName>
        <LastName>Zhang</LastName>
        <affiliation locale="en_US">School of Anesthesiology, Shandong Second Medical University, Weifang, China AND Affiliated Hospital of Shandong Second Medical University, Weifang, China</affiliation>
      </Author>
      <Author>
        <FirstName>Ying</FirstName>
        <LastName>Wang</LastName>
        <affiliation locale="en_US">School of Anesthesiology, Shandong Second Medical University, Weifang, China AND Affiliated Hospital of Shandong Second Medical University, Weifang, China</affiliation>
      </Author>
      <Author>
        <FirstName>Yingui</FirstName>
        <LastName>Sun</LastName>
        <affiliation locale="en_US">School of Anesthesiology, Shandong Second Medical University, Weifang, China AND Affiliated Hospital of Shandong Second Medical University, Weifang, China</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2024</Year>
        <Month>10</Month>
        <Day>24</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2024</Year>
        <Month>12</Month>
        <Day>01</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">We aimed to evaluate the effect of remimazolam-based general anesthesia on cellular immune function and postoperative recovery quality in patients undergoing laparoscopic radical colorectal cancer surgery.
A total of 90 patients scheduled for elective laparoscopic colorectal cancer radical surgery were randomly divided into 2 groups: the remimazolam group (Group R) and the propofol group (Group P), with 45 patients in each group. Anesthesia induction in Group R involved intravenous remimazolam, and in Group P, intravenous propofol until the loss of consciousness (modified observer&#x2019;s assessment of alertness/sedation [MOAA/S] score 1&#x2013;2). Both groups then received intravenous sufentanil and cisatracurium for intubation. Cellular immune function markers (CD3+, CD4+, CD8+ T and natural killer [NK] cells) were recorded at different time points. Quality of Recovery [QoR]-15 scale scores, hemodynamic parameters, sedation scores (Riker and Ramsay scales), recovery times and adverse events were also recorded.
Compared to Group P, Group R had significantly higher NK, CD3+, and CD4+ cell levels immediately after surgery and at 24 hours postoperatively. Group R showed a significantly lower incidence of intraoperative hypotension, bradycardia, and vasopressor use. Additionally, QoR-15 scores at 24 and 72 hours were higher in Group R. There were no significant differences in Riker or Ramsay scores, extubation time, post-anesthesia care unit stay, or the incidence of postoperative nausea, vomiting, and drowsiness between the 2 groups.
Compared with propofol, remimazolam anesthesia results in better perioperative immune function preservation, reduced intraoperative hypotension and bradycardia, and improved postoperative recovery quality in patients undergoing laparoscopic radical colorectal cancer surgery.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/4228</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/4228/2155</pdf_url>
  </Article>
</Articles>
